These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier. Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926 [TBL] [Abstract][Full Text] [Related]
6. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers. Veider F; Zöller K; Saleh A; Bernkop-Schnürch A Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708 [TBL] [Abstract][Full Text] [Related]
7. Polyphosphate coatings: A promising strategy to overcome the polycation dilemma. Le NN; Steinbring C; Le-Vinh B; Jalil A; Matuszczak B; Bernkop-Schnürch A J Colloid Interface Sci; 2021 Apr; 587():279-289. PubMed ID: 33360901 [TBL] [Abstract][Full Text] [Related]
8. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin. Zöller K; To D; Knoll P; Bernkop-Schnürch A Eur J Pharm Biopharm; 2022 Jul; 176():32-42. PubMed ID: 35584719 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933 [TBL] [Abstract][Full Text] [Related]
16. Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery. Le-Vinh B; Steinbring C; Wibel R; Friedl JD; Bernkop-Schnürch A Eur J Pharm Biopharm; 2021 Jun; 163():109-119. PubMed ID: 33775852 [TBL] [Abstract][Full Text] [Related]
17. Peptide Antibiotic-Polyphosphate Nanoparticles: A Promising Strategy to Overcome the Enzymatic and Mucus Barrier of the Intestine. Saleh A; Akkuş-Dağdeviren ZB; Haddadzadegan S; Wibel R; Bernkop-Schnürch A Biomacromolecules; 2023 Jun; 24(6):2587-2595. PubMed ID: 37224061 [TBL] [Abstract][Full Text] [Related]
18. Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations. Mura P; Maestrelli F; D'Ambrosio M; Luceri C; Cirri M Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33804945 [TBL] [Abstract][Full Text] [Related]
19. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713 [TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide? Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]